Optimal management of blood glucose levels in neurocritical patients;Manejo óptimo de la glucemia en el paciente neurocrítico

Revista de Neurologia

Volumn 51, Issue 12, 2010, Pages 745-756

  Godoy, Daniel A ^a   Rabinstein, Alejandro ^b   Videtta, Walter ^c   Murillo Cabezas, Francisco ^d  

^a Neurocritical Care Unit Sanatorio Pasteur   (Argentina)

^b MAYO CLINIC   (United States)

^c HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Glycemia management in neurocritical patients; Hyperglycemia

Indexed keywords

GLUCOSE;

ARTICLE; BLOOD GLUCOSE MONITORING; BRAIN INJURY; CLINICAL ASSESSMENT; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; NERVOUS SYSTEM INJURY; PROGNOSIS;

EID: 78650789988     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5112.2009499     Document Type: Article

References (87)

1. Bernard C. Chives rendus diabétiques. CR Soc Bilo (Paris) 1849; 1: 10.
2. Broderick JP, Hagen T, Brott T, Tomsick T. Hyperglycemia and hemorrhagic transformation of cerebral infarcts. Stroke 1995; 26: 484-487.
3. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients. Stroke 2001; 32: 2426-2432.
4. Gray CS, Hildreth AJ, Alberti GK, O'Connell JE. Poststroke hyperglycemia: natural history and immediate management. Stroke 2004; 35: 122-126.
5. Garg R, Chaudhuri A, Munschauer F, Dandona P. Hyperglycemia, insulin and acute ischemic stroke. A mechanistic justification for a trial of insulin infusion therapy. Stroke 2006; 37: 267-273.
6. Badjatia N, Topcuoglu MA, Buonanno FS, Smith EE, Nogueira RG, Rordorf GA, et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 2005; 33: 1603-1609.
7. Frontera JA, Fernández A, Claassen J, Schmidt M, Schumacher CH, Wartenberg K, et al. Hypeglycemia after subarachnoid hemorrhage. Predictors, associated complications and impact on outcome. Stroke 2006; 37: 199-203.
8. Lam AM, Winn RH, Cullen BF, Sundling N. Hyperglycemia and neurological outcome in patients with head injury. J Neurosurg 1991; 75: 545-551.
9. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000; 46: 335-343.
10. Jeremitsky E, Omert LA, Dunham CM, Wilberg J, Rodríguez A. The impact of hyperglycemia on patients with severe brain injury. J Trauma 2005; 58: 47-50.
11. Passero S, Ciacci G, Ulivelli M. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology 2003; 61: 1351-1356.
12. Fogelholm R, Murros K, Rissanen S, Avikainen S. Admission blood glucose and short term survival in primary intracerebral hemorrhage: a population based study. J Neurol Neurosurg Psychiatry 2005; 76: 349-353. (Pubitemid 40299122)
13. Godoy DA, Piñero G, Svampa S, Papa F, Di Napoli M. Hyperglycemia and short-term outcome in patients with spontaneous intracerebral hemorrhage. Neurocrit Care 2008; 9: 217-229.
14. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically patients. N Eng J Med 2001; 345: 1359-67.
15. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114: 1187-1195. (Pubitemid 40385286)
16. Magistretti PJ, Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Phil Trans R Soc Lond B 1999; 354: 1155-1163. (Pubitemid 29400898)
17. Zauner A, Daugherty WP, Bullock RM, Warner DS. Brain Oxygenation and Energy Metabolism: Part I-Biological function and pathophysiology. Neurosurgery 2002; 51: 289-302.
18. Vespa P, Boonyaputthikul BS, McArthur DL, Miller C, Etchepare M, Bergsneider M, et al. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/piruvate ratio after traumatic brain injury. Crit Care Med 2006; 34: 850-856.
19. Oddo M, Schmidt M, Carrera E, Badjatia N, Sander-Connolly E, Presciutti M, et al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury. A microdialysis study. Crit Care Med 2008; 36: 3233-8.
20. Bergsneider M, Hovda DA, Shalmon E, Kelly DF, Vespa PM, Martin NA, et al. Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg 1997; 86: 241-251.
21. Vespa PM, Mc Arthur D, O'Phelan K, Glenn T, Etchepare M, Kelly D, et al. Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate. A microdialysis study. J Cereb Blood Flow Metab 2003; 23: 865-877.
22. Vespa PM, Bergsneider M, Hattori N, Wu HM, Huang SC, Martin NA, et al. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab 2005; 25: 763-774.
23. D'Avella D, Cicciarello R, Zuccarello M, Albiero F, Romano A, Angileri FF, et al. Brain energy metabolism in the acute stage of experimental subarachnoid hemorrhage: local changes in cerebral glucosa utilization. Acta Neurochir (Wien) 1996; 138: 737-743.
24. Brown AM, Ransom BR. Astrocyte glycogen and brain energy metabolism. Glia 2007; 55: 1263-1271.
25. Vázquez-Cruz J, Álvarez-Sabín J. Efecto de la glucosa en la isquemia cerebral. Rev Neurol 1990; 18: 153-155.
26. Auer R. Hypoglycemic brain damage. Forensic Sci Int 2004; 146: 105-110. (Pubitemid 39470146)
27. Sieber FE, Traystman RJ. Glucose and the brain. Crit Care Med 1991; 20: 104-114.
28. Suh SW, Hamby AM, Swanson RA. Hypoglycemia, brain energetics and hypoglycaemic neuronal death. Glia 2007; 55: 1280-1286.
29. Bilotta F, Giovannini F, Caramia R, Rosa G. Glycemia management in neurocritical care patients: a review. J Neurosurg Anesthesiol 2009; 21: 2-9.
30. McCormick MT, Muir KW, Gray CS, Walters MR. Management of hyperglycemia in acute stroke. How, when, and for whom? Stroke 2008; 39: 2177-2185.
31. Stead LG, Gilmore RM, Bellolio MF, Mishra S, Bhagra A, Vaidyanathan L, et al. Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke. Neurocrit Care 2009; 10: 181-186.
32. Fuentes B, Castillo J, San José B, Leira R, Serena J, Vivancos J, et al. Stroke Project of the Cerebrovascular Diseases Study Group, Spanish Society of Neurology. The prognostic value of capillary glucose levels in acute stroke: the Glycemia in Acute Stroke (GLIAS) Study 2009; 40: 562-568.
33. Álvarez-Sabín J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribó M, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 2003; 34: 1235-1241.
34. Álvarez-Sabín J, Molina CA, Ribó M, Arenillas JF, Montaner J, Huertas R, et al. Impact of admission hyperglycemia on stroke outcome after thrombolysis. Risk stratification in relation to time to reperfusión. Stroke 2004; 35: 2393-2499.
35. Ribó M, Molina CA, Montaner J, Rubiera M, Delgado-Mederos R, Arenillas JF, et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke 2005; 36: 1705-1709.
36. Ribó M, Molina CA, Delgado P, Delgado-Mederos R, Rovira A, Munuera J, et al. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA. J Cereb Blood Flow Metb 2007; 27: 1616-1622.
37. Kruyt ND, Roos YM, Dorhout-Mess SM, Van der Bergh WM, Algra A, Rinkel GJE, et al. High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischaemia after aneurismal subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry 2008; 79: 1382-1385.
38. MRC CRASH Trial Collaborators. Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients. BMJ 2008 23; 336: 425-429.
39. Salim A, Hadjizacharia P, Dubose J, Brown C, Inaba K, Chan LS, et al. Persistent hyperglycemia in severe traumatic brain injury: an independent predictor of outcome. Am Surg 2009; 75: 25-29.
40. Nagamizo D, Tsuruta S, Matsumoto M, Matayoshi H, Yasamita A, Sakabe T. Tight glycemic control by insulin, started in the preischemic, but not postischemic, period, protects against ischemic spinal cord injury in rabbits. Anesth Analg 2007; 105: 1397-1403. (Pubitemid 350303947)
41. Allport L, Butcher K, Baird T, MacGregor L, Desmond PM, Tress BM, et al. Acute stress hyperglycemia is associated with insular cortical ischemia. Stroke 2004; 35: 248.
42. Moreton FC, McCormick M, Muir KW. Insular cortex hypoperfusion and acute phase blood glucose after stroke: a CT perfusion study. Stroke 2007; 38: 407-410.
43. Mechanick JI. Metabolic mechanisms of stress hyperglycemia. J Parent Enteral Nutr 2006; 30: 157-163.
44. Van Kooten F, Hoogerbrugge N, Naarding P, Koudstaal PJ. Hyperglycemia in the acute phase of stroke is not caused by stress. Stroke 1993; 24: 1129-1132.
45. McKeating EG, Andrews JD. Cytokine and adhesion molecules in acute brain injury. Br J Anaesth 1998; 80: 77-84.
46. Wilcockson DC, Campbell SJ, Anthony DC, Perry VH. The systemic and local acute phase response following acute brain injury. J Cereb Blood Flow Metab 2002; 22: 318-326.
47. Marquardt L, Ruf A, Mansmann U, Winter R, Buggle F, Kallenberg K, et al. Inflammatory response after acute ischemic stroke. J Neurol Sci 2005; 236: 65-71.
48. Prunell GF, Svendgaard NA, Alkass K, Mathiesen T. Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery 2005; 56: 1082-1092.
49. Godoy D, Piñero G. Inflammatory response in spontaneous intracerebral hemorrhage. Rev Neurol 2005, 40: 492-497.
50. McCowen KC, Malhotra A, Bistrian BR. Stress induced hyperglycemia. Crit Care Clin 2001; 17: 107-124.
51. Tomlinson DR, Gardner NJ. Glucose neurotoxicity. Nat Rev Neurosci 2008; 9: 36-45.
52. Allport L, Baird T, Butcher K, MacGregor L, Prosser J, Colman P, et al. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care 2006; 29: 1839-1844.
53. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycaemia in humans. Circulation 2002; 106: 2067-2072.
54. Prakash A, Matta BF. Hyperglycemia and neurological injury. Curr Opin Anaesthesiol 2008; 21: 565-569.
55. Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am J Cardiol 2007; 99: 15-26.
56. Dandona P. Endothelium, inflammation, and diabetes. Curr Diab Rep 2002; 2: 311-315.
57. Adams HP Jr, Brott TG, Furlan AJ, Gómez CR, Grotta J, Helgason CM, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1996; 94: 1167-1174.
58. Adams HP Jr, Del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association, Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups [published corrections appear in Stroke 2007; 38: e38 and 2007; 38: e96]. Stroke 2007; 38: 1655-1711.
59. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
60. Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2007; 24 (Suppl 1): S1-S106.
61. Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, et al. Association. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009; 40: 994-1025.
62. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/ American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007; 38: 2001-2023.
63. The European Stroke Initiative Writing Committee and the writing committee for the EUSI Executive committee. Recommendations for the management of intracranial hemorrhage. Part I: spontaneous intracerebral hemorrhage. Cerebrovasc Dis 2006; 22: 294-316.
64. Fahy BG, Sheehy AM, Coursin D. Glucose control in the intensive care unit. Crit Care Med 2009; 37: 1769-1776.
65. The NICE-SUGAR Study investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297.
66. Inzucchi SE, Siegel MD. Glucose control in the ICU -how tight is too tight? N Engl J Med 2009; 360: 1346-1349.
67. Oddo M, Schmidt JM, Mayer SA, Chiolero RL. Glucose control after brain injury. Curr Opin Clin Nutr Metab Care 2008; 11: 134-139.
68. Nordstrom CH. Insulin, intracerebral glucose and beside biochemical monitoring utilizing microdialysis. Crit Care 2008; 12: 124.
69. Schlenk F, Graetz D, Nagel A, Schmidt M, Sarrafzadeh AS. Insulin-related decrease in cerebral glucose despite normoglycemia in aneurismal subarachnoid hemorrhage. Crit Care 2008; 12: 9.
70. Holbein M, Bechir M, Ludwing S, Sommerfeld J, Cottini SR, Keel M, et al. Differential influence of arterial blood glucose on cerebral metabolism following severe traumatic brain injury. Crit Care 2009; 13: 13.
71. Gentile NT, Seftchick MW, Huynh BS, Kruus LK, Gaughaan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006; 13: 174-180.
72. Walters MR, Weir CJ, Lees KR. A randomized, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischemic stroke patients. Cerebrovasc Dis 2006; 22: 116-122.
73. Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, et al. Treatment of hyperglycemia in ischemic stroke (THIS). A randomized pilot trial. Stroke 2008; 39: 384-389.
74. Gray SC, Hildreth AJ, Sandercock PA, O'Donnell JE, Johnston DE, Cartlidge NEF, et al, for the GIST Trialists Collaboration. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007; 6: 397-406.
75. Glucose Regulation in Acute Stroke Patients (GRASP) Study. URL: http://clinicaltrials.gov/ct2/show/study/NCT00282867?view=results. [09.10.2009].
76. Bilotta F, Caramia R, Paoloni FP, Delfini R. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology 2009; 110: 611-619.
77. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage. A randomized prospective pilot trial. J Neurosurg Anesthesiol 2007; 19: 156-160.
78. Latorre JGS, Hsiang-Yi Chou S, Gomes-Nogueira R, Singhal AB, Carter BS, Ogilvy CS, et al. Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurismal subarachnoid hemorrhage. Stroke 2009; 40: 1644-1652.
79. Bilotta F, Caramia R, Cernak I, Paoloni FP, Doronzio A, Cuzzone V, et al. Intensive insulin therapy alter severe traumatic brain injury: a randomized clinical trial. Neurocrit Care 2008; 9: 159-166.
80. Meier R, Bechir M, Ludwing S, Sommerfeld J, Keel M, Steiger P, et al. Differential temporal profile of lowered blood glucose levels (3.5 to 6.5 mmol/l versus 5 to 8 mmol/l) in patients with severe traumatic brain injury. Crit Care 2008; 12: 98.
81. Rodríguez-Ku RJ. Síndrome metabólico y enfermedad vascular cerebral: evidencias en su tratamiento. Rev Neurol 2009; 48: 255-260.
82. Alonso De Leciñana-Cases M, Egido JA, en nombre del Comité de Redacción ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN. Manejo del infarto cerebral en fase aguda. Neurologia 1998; 13 (Supl 3): S13-s23.
83. Egido GA, Alonso de Leciñana-Cases M, Martínez-Vila E, Díez-Tejedor E, en representación del Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología. Guía para el tratamiento del infarto cerebral agudo. Neurologia 2002; 17 (Supl 3): S43-S60.
84. Moghissi ES, Korytkowsky MT, Di Nardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of clinical endocrinologist and American diabetes association consensus statement on inpatient glycemic control. Diabetes Care 2009; 32: 1119-1131.
85. Vespa P. Intensive glycemic control in traumatic brain injury: what is the ideal glucose range? Crit Care 2008; 12: 175.
86. Egido JA, Alonso de Leciñana-Cases M, Martínez-Vila E, Díez-Tejedor E, por el Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN. Guía para el tratamiento del infarto cerebral agudo. In Díez-Tejedor E, ed. Guía para el diagnóstico y tratamiento del ictus. Guía de la Sociedad Española de Neurología. Barcelona: Prous Science; 2006. p. 97-132.
87. Alonso de Leciñana-Cases M, Pérez-R GE, Díez-Tejedor E, en representación de la SIECV. Recomendaciones para el tratamiento y prevención del ictus, 2004. Rev Neurol 2004; 39: 465-486.